The International Myeloma Working Group (IMWG), which comprises 85 investigators  specializing in the area of multiple myeloma, has reviewed and considered the recent Mayo Clinic consensus statement for the use of bisphosphonates (BPs) in multiple myeloma. Although the IMWG is in general agreement with the Mayo consensus statement, several important issues have been raised and are discussed subsequently. These comments are in response to the recommendations of  the Mayo group, which is normally part of the IMWG.


Durie BG

Mayo Clin Proc. 2007 Apr;82(4):516-7; author reply 517-8.

Click here to view Article